Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

An Interview with ACR Honoree Rep. Raul Ruiz on Step Therapy Reform

Carol Patton  |  Issue: December 2019  |  October 17, 2019

The Safe Step Act helps ensure that physicians and patients, not insurance company administrators, have the authority to make treatment decisions that are best for patients.

TR: Is there anything else you plan on doing to support this legislation?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Rep. Ruiz: I will continue working with my colleagues in Congress as well as patient advocates to bring attention to this important issue, uphold the integrity of the doctor-patient relationships, and ensure patients can access the medications they need.

Get Involved
You can do your part to rein in step therapy by asking your representatives in Washington, D.C., to join Rep. Ruiz and others in supporting step therapy reform. Go to the ACR’s Legislative Action Center to send a pre-written message to your legislators.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Carol Patton, a freelance writer based in Las Vegas, writes the Rheum After 5 column for The Rheumatologist.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportProfiles Tagged with:Award for Public Leadership in RheumatologyRep. Raul RuizSafe Step Act of 2019 (H.R. 2279)step therapy

Related Articles

    Clinical Challenges in SLE: Glucocorticoids—How Much Is Too Much?

    July 22, 2022

    Glucocorticoids remain a prominent part of care for many patients with SLE but can have toxic side effects; this EULAR 2022 session discussed one institution’s approach to lower the dosage.

    State of RheumPAC: 2015 Annual Report

    May 13, 2016

    Dear Friends and Colleagues, With your strong support and commitment, RheumPAC has grown again for the eighth straight year, allowing us to do even more on your behalf. Not only did we exceed our original goal by raising more than $150,000. More importantly, these donations came from nearly 350 ACR and ARHP members—a new record….

    The 2020 ARP Merit Awards & ACR Distinguished Fellows

    December 14, 2020

    During ACR Convergence 2020 in early November, the ACR and ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards and the ACR’s Distinguished Fellows. In addition, we bring you the first ever…

    The 75-Year History of PANLAR

    April 26, 2018

    The first organization dedicated to fighting rheumatic disease was the International League Against Rheumatism (ILAR), founded in 1928 under the guidance of a Dutch national, Dr. Jan van Breemen. Interest in rheumatology quickly spread throughout the American continent, and the American Association for the Study and Control of Rheumatism met in Cleveland, for what they…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences